Obesity News

Adults who previously used an obesity medication before receiving semaglutide lost less body weight at 12 months than those who did not use an obesity medication before semaglutide, according to study findings.

BOSTON — Intermittent fasting is a popular weight loss technique, but there are a few considerations that physicians should keep in mind when discussing it with their patients, according to a presenter at the ACP Internal Medicine Meeting.

BOSTON — Time-restricted eating did not result in more weight loss vs. a usual eating pattern, suggesting that overall caloric intake may have a larger effect on weight loss than meal timing, researchers reported.

Some changes in gut microbiome composition may increase the risk for obesity, with those changes affecting men and women differently, according to data that will be presented at the European Congress on Obesity.

Hundreds of clinicians will gather in Denver next week to discuss the latest treatment strategies and evidence-based approaches to obesity management.

Adults with moderate to severe obstructive sleep apnea and obesity had reductions in sleep apnea severity at 1 year with 10 mg or 15 mg of tirzepatide, according to topline results from two phase 3 trials.

Individuals with obesity have long felt stigmatized and shamed in health care settings.

ATLANTA — Adults with obesity, HF with preserved ejection fraction and type 2 diabetes saw marked improvements in HF symptoms and physical function with semaglutide 2.4 mg compared with placebo, despite less than typical weight loss.

The impact of social determinants of health on cardiovascular risk factors may vary across Asian American subgroups such as Filipino, Asian Indian, Chinese and other Asian populations, researchers reported.